EP Patent

EP2923694A1 — Oral liquid pharmaceutical solution of gabapentin

Assigned to Sanovel Ilac Sanayi ve Ticaret AS · Expires 2015-09-30 · 11y expired

What this patent protects

The present invention relates to an oral liquid pharmaceutical solution comprising gabapentin or a pharmaceutically acceptable salt, solvate or hydrate thereof and disodium EDTA as an antioxidant and one or more pharmaceutically acceptable excipients.

USPTO Abstract

The present invention relates to an oral liquid pharmaceutical solution comprising gabapentin or a pharmaceutically acceptable salt, solvate or hydrate thereof and disodium EDTA as an antioxidant and one or more pharmaceutically acceptable excipients.

Drugs covered by this patent

Patent Metadata

Patent number: EP2923694A1
Jurisdiction: EP
Classification: —
Expires: 2015-09-30
Drug substance claim: No
Drug product claim: No
Assignee: Sanovel Ilac Sanayi ve Ticaret AS
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.